$ETON

1 thesis
bullish 0%neutral 0%bearish 100%
Avg return (3m)
—
Win rate (3m)
— (0 resolved)

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Aug 24, 1:28 PM ET
$ETONSEC Form 4bearish
Sold 100,000 @ $60.88 avg · $6,087,773 · 2026-08-19

Form 4: BRYNJELSEN SEAN sold ETON

BRYNJELSEN SEAN (President & CEO at Eton Pharmaceuticals, Inc.) reported an open-market sale of 100,000 shares of ETON at an average $60.88, roughly $6,087,773, in a Form 4 filed 2026-08-20.

At post $59.91Now $64.58+7.8% since postedas of Aug 24, 1:28 PM ET
1d+5.9%
3d+5.9%
1w+4.6%
1m-7.4%
3m—
6m—
1y—
View filing on SEC.gov →

End of results.